IQE PLC
28 February 2008
IQE plc
(the ''Company'' or ''IQE'')
Notification of Interest
The Company was informed on 27 February 2008 that Gartmore Investment Limited
and its subsidiaries ('Gartmore') had a notifiable interest of 44,218,440
ordinary shares in IQE, being 10.3% of the issued share capital of the Company.
Gartmore is interested in IQE through the entities as detailed below:
Registered Holding Beneficial Owner Number of
ordinary shares
HSBC Global Custody Gartmore Fund Managers LTD 17,824,080
Nominee UK LTD A/C Gartmore UK & Irish Smaller
Companies
BNY GIL A/C Noms LTD A/C NWSC Gartmore Growth Opportunities plc 3,486,494
BNY GIL A/C Noms LTD A/C LST Gartmore Smaller Companies Trust 7,824,300
plc
Nortrust Nominees Limited Strathclyde Pension Fund 15,083,566
Total 44,218,440
The total number of the Company's ordinary shares in issue is 431,043,197.
The ordinary shares referred to above are the ordinary shares of 1 pence each.
Contacts
IQE plc +44(0) 29 2083 9400
Leslie Coventry
Noble & Company Limited +44(0) 20 7763 2200
John Llewellyn-Lloyd
Andy Yeo
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.